doc

Dr. Romeo Stockett, PhD

Founder

Founder

Dr. Romeo P. Stockett, MPH, PhD, a native of Washington DC, has been engaged in education, public health, and health equity for more than 50 years of his professional life. He is a retired US Air Force officer and has since served in many and varied public health leadership roles. He has held leadership positions at every level of public health and educational arenas, including federal, state, county, local, rural, and international.

Dr. Stockett’s educational experiences have been equally comprehensive, having taught at the University the Maryland, St Joseph University and Morehouse School of Medicine while serving at the Department of Human Services, Centers for Disease Control and Prevention, County Director of School Health, The State Office of Vital Records and numerous lecturing and consulting roles.

Dr. Stockett is currently deeply engaged in the exploration of the pursuit of health equity in all aspects of health care, including clinical, administrative, pharmaceutical, management and philosophically.

It is from this background, years of experience and his awareness of the genius and potential harnessed in this and future generations that he recognizes that there should never be a place for the policies or practices of inequities based on gender, race, station, zip code, or any other classification.  One of the most glaring theaters of health care inequities are in the areas of research and clinical trials.  The broadly practiced approach to medical research and clinical trials in this country has been to focus on the majority population, then try to retrofit how the findings affect minority populations of black and brown people.  This approach is both too time consuming and ineffective.

Thus, the establishment and implementation of The Consortium for Black Health Research and Clinical Trials.

Dr Stockett resides in Atlanta, GA with his wife and business partner, Rochelle.  He has 8 adult children and numerous great-grandchildren.

“Fostering targeted research and clinical trials on the populations most impacted to achieve enhanced efficacy of the results”